Insulin: an emerging treatment for Alzheimer's disease dementia? - Wikidata - wikimedia - TriplyDB

Insulin: an emerging treatment for Alzheimer's disease dementia?

Insulin: an emerging treatment for Alzheimer's disease dementia?

http://www.wikidata.org/entity/Q26827376

about

Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.The synergistic effects of HIV, diabetes, and aging on cognition: implications for practice and research Early adult to midlife cardiovascular risk factors and cognitive function.Cognitively impaired elderly exhibit insulin resistance and no memory improvement with infused insulin Recent Developments in Understanding Brain Aging: Implications for Alzheimer's Disease and Vascular Cognitive Impairment.Effects of APP 5-mer peptide analogue P165 on the synaptic proteins and insulin signal transduction proteins Insulin at a unicellular eukaryote level.Activation of mTOR: a culprit of Alzheimer's disease?Perspectives for treating Alzheimer's disease: a review on promising pharmacological substances.Erythrocytes as Potential Link between Diabetes and Alzheimer's Disease Association between insulin and executive functioning in alcohol dependence: a pilot study.The serum metabolomics signature of Type 2 Diabetes is obscured in Alzheimer's Disease.The impact of dementia on antidiabetic drug use in Medicare beneficiaries with diabetes: findings post-Medicare part D.Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits.Suppressor of Cytokine Signaling 3: Emerging Role Linking Central Insulin Resistance and Alzheimer’s Disease.The effects of insulin on the inflammatory activity of BV2 microglia

P2860

Q26830845-BFC5BA53-DD95-4E8A-B175-6AA350C9F1B8 Q33783000-A065571B-BAC5-46E7-9B64-4E11B5C63C31 Q34143299-5FA6CAA7-F0F6-4A97-B14F-8421EFED5F1F Q36429211-37B5DD41-E993-4A10-AC73-7C96CE519B41 Q36638737-CF172E35-1CB4-4515-BE62-10A06DA89359 Q36853502-C722D96D-F5C8-4C10-950D-3FDDA6EA79F2 Q37711437-ABCB0211-7F05-439F-823A-5EB614476B83 Q38086148-F84DBD27-5F67-412E-A73A-13A54B8E30D2 Q38443497-3E7BE61E-F26C-49EC-B134-CCA1DD95D4B6 Q38936146-B922CBE6-C748-4466-A956-24A568E4E2D0 Q41547214-22B60779-D0F8-447D-AB46-922E8FC79802 Q42025769-11018F34-4971-4691-8200-22E77E73889E Q49917617-9E6F142B-B2C2-4453-974B-D33272E66500 Q53378774-4B5AAC6A-5A99-4A0E-BD0E-69F4AB514413 Q55353865-7913FEB7-ED7B-4DE2-8DB0-CC7B275F60AE Q55405257-EA09B177-1F55-4B8D-9315-DA76D7A4BAAB Q58701739-3D8EB814-C0B2-429B-A612-71131C66AC52

P2860

Insulin: an emerging treatment for Alzheimer's disease dementia?

http://www.wikidata.org/entity/Q26827376

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Insulin: an emerging treatment for Alzheimer's disease dementia?

@ast

Insulin: an emerging treatment for Alzheimer's disease dementia?

@en

Insulin: an emerging treatment for Alzheimer's disease dementia?

@nl

type

label

Insulin: an emerging treatment for Alzheimer's disease dementia?

@ast

Insulin: an emerging treatment for Alzheimer's disease dementia?

@en

Insulin: an emerging treatment for Alzheimer's disease dementia?

@nl

prefLabel

Insulin: an emerging treatment for Alzheimer's disease dementia?

@ast

Insulin: an emerging treatment for Alzheimer's disease dementia?

@en

Insulin: an emerging treatment for Alzheimer's disease dementia?

@nl

P1433

Q26827376-5AC95720-937F-4849-9D03-3D9500569E4F

P1476

Q26827376-1FA270FA-23C0-4C5B-B5BC-4B22E2D91164

P2093

Q26827376-5CAD85D3-E422-436D-A5A2-B8531E34B2FB

Q26827376-9906967D-9718-4B07-BA1A-62507F90D585

P2860

Q26827376-004BA89C-261C-41A5-A276-17536B470C74

Q26827376-004E23A8-511B-4EC3-ACDD-6904AAF60024

Q26827376-03A74FC7-83BA-4EFD-9062-A70509ABF35D

Q26827376-0861D209-6904-4D4A-AA90-F0122B78133C

Q26827376-0D3DAF96-1F97-4E7B-B7F8-5006ADF87D27

Q26827376-102C8E9E-25E0-4A54-B184-0309F73B8250

Q26827376-12D0408F-9F29-439C-BB44-0C17D73D35F8

Q26827376-17ABBD0D-3AFE-45F7-B6AC-CBBBA14DD7E6

Q26827376-190B5522-0135-4817-9670-4C059638760D

Q26827376-1B16402F-9E17-46A0-BBA6-6A19B2E998B6

P2888

Q26827376-8552C4FC-4B76-4636-B0D7-359A91E9D1BE

P304

Q26827376-DE68A1F5-B6DC-4E0B-9389-18A444371F41

P31

Q26827376-9A45A10A-1E3F-4AAD-A994-4ADCC77DF5B0

P356

Q26827376-1F00D164-0FC6-4877-A43D-35F01BFF2B35

P407

Q26827376-5918C21B-4BD4-492E-AEDD-0F548EA4B450

P433

Q26827376-79E0E4AA-431C-4A73-8AC4-5DE6DBA61409

P478

Q26827376-2F9A62B2-F21C-40FA-90F2-6933547094A7

P577

Q26827376-BE6C67AD-0A33-4328-B4D7-7A110B67F8D7

P5875

Q26827376-565132F3-2D3F-4336-823E-2307E58C3E9B

P6179

Q26827376-A7F0292E-A4CB-4092-AA52-24638C498CB3

P698

Q26827376-1D7BE454-6335-4BB5-8EC0-F696F738F262

P921

Q26827376-1598C48F-86BB-4CE2-AC28-FDC6E2DE721F

Q26827376-2B7052EB-A7AB-49C8-AEAA-11D2ADF046CF

Q26827376-444A56E0-67E3-4CA3-A5AA-C39C6993BEAE

P932

Q26827376-7000CB26-F245-4A43-B8DC-12FA209CAF15

P356

S11910-012-0297-0

P1433

Current Neurology and Neuroscience Reports

P1476

Insulin: an emerging treatment for Alzheimer's disease dementia?

@en

P2093

Jeffrey M. Burns

http://www.w3.org/2001/XMLSchema#string

Jill K. Morris

http://www.w3.org/2001/XMLSchema#string

P2860

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

Insulin signalling and the regulation of glucose and lipid metabolism

Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study

Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

Type 2 diabetes mellitus, cognitive impairment and dementia.

Effects of insulin and octreotide on memory and growth hormone in Alzheimer's disease

Insulin reduces neuronal excitability by turning on GABA(A) channels that generate tonic current.

P2888

s11910-012-0297-0

P304

520-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11910-012-0297-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229082301

http://www.w3.org/2001/XMLSchema#string

P6179

1035962344

http://www.w3.org/2001/XMLSchema#string

P698

22791280

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3540744

http://www.w3.org/2001/XMLSchema#string